BRIEF published on 11/02/2024 at 16:15, 1 year 6 months ago Savencia Cheese USA Voluntarily Recalls Select Cheeses Due to Listeria Risk Health Risks Listeria Recall Soft Cheeses FDA Coordination Savencia Cheese USA
PRESS RELEASE published on 11/02/2024 at 16:10, 1 year 6 months ago Savencia Cheese USA Announces Voluntary Recall of Select Soft Ripened Cheeses Savencia Cheese USA announces voluntary recall of select soft ripened cheeses due to potential Listeria monocytogenes contamination. Consumers advised to check product labels for identification Voluntary Recall Consumer Safety Savencia Cheese USA Listeria Monocytogenes Product Labels
BRIEF published on 10/24/2024 at 07:51, 1 year 6 months ago Savencia performance at the end of September 2024 International Market Organic Growth Turnover Dairy Products Savencia
BRIEF published on 10/24/2024 at 07:51, 1 year 6 months ago Performance de Savencia à fin septembre 2024 Chiffre D'affaires Croissance Organique Marché International Produits Laitiers Savencia
PRESS RELEASE published on 10/24/2024 at 07:46, 1 year 6 months ago SAVENCIA: Activity at the end of September 2024 Savencia Fromage & Dairy Group reports 1.3% sales growth in September 2024 driven by Other Dairy Products and favorable structural effects. Commitment to quality and sustainability initiatives highlighted Sustainability Sales Growth Commitments Savencia Dairy Group
PRESS RELEASE published on 10/24/2024 at 07:46, 1 year 6 months ago SAVENCIA : Activité à fin septembre 2024 Le chiffre d'affaires du Groupe Savencia Fromage & Dairy progresse de 1,3% à fin septembre 2024, porté par la croissance organique des Autres Produits Laitiers et un effet de structure positif Chiffre D'affaires Croissance Organique Engagements RSE Savencia Fromage & Dairy Effet De Structure
BRIEF published on 09/19/2024 at 19:05, 1 year 8 months ago Savencia announces its 2024 half-year financial results Finance Net Profit Turnover Half-yearly Results Savencia
BRIEF published on 09/19/2024 at 19:05, 1 year 8 months ago Savencia annonce ses résultats financiers semestriels 2024 Chiffre D'affaires Résultats Semestriels Finances Bénéfice Net Savencia
PRESS RELEASE published on 09/19/2024 at 19:00, 1 year 8 months ago SAVENCIA: 2024 Half-yearly financial report SAVENCIA SA releases condensed interim consolidated financial statements as of June 30, 2024, showing positive growth in net sales and earnings. Detailed breakdown of income, assets, and equity included Balance Sheet Interim Financial Statements Income Statement June 30 2024 Savencia SA
PRESS RELEASE published on 09/19/2024 at 19:00, 1 year 8 months ago SAVENCIA : Rapport Financier Semestriel 2024 États financiers consolidés semestriels résumés de Savencia SA au 30 juin 2024, incluant compte de résultat, bilan, flux de trésorerie et variation des capitaux propres États Financiers 30 Juin 2024 Savencia SA Consolidés Semestriels
Published on 05/23/2026 at 03:15, 9 hours 37 minutes ago UraniumX Approved for Trading on the OTCQB Venture Market and Announces Board Change
Published on 05/23/2026 at 03:00, 9 hours 52 minutes ago Battery X Metals Reports Up to ~84 km Estimated Driving Range Increase Across Multiple BYD Electric Vehicles Following Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Trials, Demonstrating Performance Improvement Across the World’s Larges
Published on 05/23/2026 at 02:25, 10 hours 27 minutes ago Battery X Metals Announces up to $2 Million Private Placement Financing and Initiative to Strengthen Balance Sheet
Published on 05/23/2026 at 02:25, 10 hours 27 minutes ago Bolt Metals Completes 402 line-km MobileMT Survey at Northwind Property, Quebec
Published on 05/23/2026 at 01:00, 11 hours 52 minutes ago LIR Life Sciences Announces Initiation of Phase 1 Macromolecule-Enabled Transdermal Delivery Development with Neuland Laboratories
Published on 05/22/2026 at 22:05, 14 hours 47 minutes ago Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH
Published on 05/22/2026 at 22:05, 14 hours 47 minutes ago Abivax Presents Q1 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with UC
Published on 05/22/2026 at 19:51, 17 hours ago Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices
Published on 05/22/2026 at 18:33, 18 hours 19 minutes ago Update on Coupon payment due on 23 May 2026 and Preparation of the Green Bond Restructuring
Published on 05/22/2026 at 18:30, 18 hours 21 minutes ago Annual General Meeting of Curatis Holding AG approved all proposals of the Board of Directors
Published on 05/22/2026 at 19:35, 17 hours 17 minutes ago PROJET D'EVOLUTION DE SA GOUVERNANCE ET LA NOMINATION D'UN PRESIDENT DU DIRECTOIRE PAR INTERIM
Published on 05/22/2026 at 18:05, 18 hours 46 minutes ago Déclaration hebdomadaire d'opérations effectuées du 18 au 22 mai 2026
Published on 05/22/2026 at 18:05, 18 hours 46 minutes ago Disclosure of transactions in own shares from May 18 to May 22, 2026
Published on 05/22/2026 at 12:52, 23 hours 59 minutes ago Communiqué du Conseil d’administration – Assemblée Générale du 22 mai 2026
Published on 05/22/2026 at 12:52, 23 hours 59 minutes ago Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026
